EKSO stock: buy or sell?
April 6th, 2020
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa.
Should I buy EKSO stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. That's why is so important to choose your own trading strategy that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Ekso Bionics stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Ekso Bionics stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for EKSO stock for the last 30 days.
EKSO stock analysis
After sliding for 4 sessions, Monday Ekso Bionics skyrocketed a dazzling 8.24%, closing at $2.76.
After sliding for 4 sessions, Monday Ekso Bionics skyrocketed a dazzling 8.24%, closing at $2.76. Since December when EKSO stock price broke down the SMA50d line, it slid $-6.02 per share (-68.56%).
After sliding a frightening -47.06% in a week last week, Ekso Bionics closed this week at $2.76 and climbed an exceptional 8.24%.
Since early May 2019, when EKSO stock price broke down the 40-weeks moving avarage line, it slid $-30.24 per share (-91.64%). Stocks under the 200 days moving average line are usually not recommended for average traders.
EKSO stock price history
EKSO stock went public on January 17th, 2014 with a price of $252.001. Since then, EKSO stock lost a -98.90%, with a yearly average of -16.50%.
1: Adjusted price after possible price splits or reverse-splits.
EKSO stock historical price chart
EKSO stock reached 52-week highs at $38.25, and all-time highs 2014-02-24 with a price of 863.1.
EKSO stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we have not detected any price target for Ekso Bionics stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, Ekso Bionics didn't meet the expectations of the analysts and posted a tragic EPS of $-0.07 per share when experts were expecting $-0.08.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw an exceptional gain of 54.11% to $11.33 M dollars. Likewise, its earnings margin (compared to sales) boosted to -238.19%, that is $-26.99 million.
|2013||$3.30 M||-||$-11.89 M-360.3%||-|
|2014||$5.33 M||61.42%||$-33.77 M-633.9%||184.01%|
|2015||$8.66 M||62.59%||$-19.59 M-226.2%||-41.99%|
|2016||$14 M||64.20%||$-23.47 M-165.0%||19.81%|
|2017||$7.35 M||-48.29%||$-29.12 M-396.1%||24.08%|
|2018||$11 M||54.11%||$-26.99 M-238.2%||-7.31%|
Quarterly financial resultsEkso Bionics posted $3.30 M in revenues for 2018-Q4, a 29.25% up compared to previous quarter. Reported quarter earnings marked $-4.13 million with a profit margin of -125.36%. Profit margin climbed a 148.48% compared to previous quarter when profit margin was -273.84%. When comparing revenues to same quarter last year, Ekso Bionics sales marked an outstanding gain and rocketed a 34.37%.
|2017-Q2||$2 M||-||$-5.51 M-294.7%||-|
|2017-Q3||$2 M||-14.60%||$-6.34 M-396.7%||14.97%|
|2017-Q4||$2 M||53.60%||$-8.98 M-366.0%||41.72%|
|2018-Q1||$3 M||2.65%||$-7.90 M-313.8%||-12.00%|
|2018-Q2||$3 M||17.83%||$-7.98 M-268.9%||0.97%|
|2018-Q3||$3 M||-14.05%||$-6.98 M-273.8%||-12.47%|
|2018-Q4||$3 M||29.25%||$-4.13 M-125.4%||-40.83%|
|2019-Q1||$4 M||9.71%||$-6.55 M-181.2%||58.54%|
Ekso Bionics ownershipWhen you are planning to invest in a stock, it's always worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Ekso Bionics, 1.24% of all outstanding shares are owned by its staff.
In case of Ekso Bionics stock, 27.86% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for EKSO stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related companies:
|Market cap||$240.3 M|
|Total shares||87.1 M|
|Float shares||74.4 M|
|- Institutional holdings (%)||27.9%|
|- Insider holdings (%)||1.2%|
|Shares in short selling||0.0%|
|Monday, April 6th, 2020|
|Day range||$2.55 - $2.84|
|Average true range||$0.51|
|50d mov avg||$4.51|
|100d mov avg||$5.82|
|200d mov avg||$9.06|
Ekso Bionics performanceTo better understand Ekso Bionics performance you must compare its gains with other related stocks in same sector or industry. We chose as the bechmarking frame for Ekso Bionics stock.